Exagen_Full_CMYK_Print.jpg
AVISE® MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout
24 oct. 2019 08h20 HE | Exagen, Inc.
SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), is pleased to announce clinical study support for Horizon Therapeutics plc (Nasdaq: HZNP) to measure methotrexate...
Exagen and the Unive
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research
19 août 2019 08h57 HE | Exagen Inc.
San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
JEFFREY THOMAS ELLIO
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
26 mars 2019 08h45 HE | Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...